AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Sitapride-M 50mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Micro Labs Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitapride-M 50mg/500mg Tablet PR

Diabetic patients with type 2 mellitus may benefit from the dual-action formulation, Sitapride-M 50mg/500mg Tablet PR, which effectively manages elevated blood glucose. This combination therapy mitigates the risk of severe diabetic complications, including renal impairment and vision loss, and potentially lowers the probability of cardiovascular events. Sitapride-M 50mg/500mg Tablet PR can be administered independently or concurrently with other antidiabetic agents. Optimal efficacy is achieved when combined with a balanced diet and regular physical activity. Dosage is individualized based on patient condition, glycemic control, and concomitant medications. Consuming the medication with meals minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise regime is crucial for successful diabetes management, as lifestyle significantly influences glycemic control. Commonly reported adverse events include nausea, vomiting, diarrhea, abdominal distress, headache, and pharyngitis. Hypoglycemia, a potential side effect, particularly when used with insulin or sulfonylureas, requires patient awareness and appropriate management strategies. Prior to initiating treatment, individuals with pre-existing renal, hepatic, or cardiac conditions, pancreatic disorders, or significant alcohol consumption should inform their physician. Pregnant or lactating women should seek medical consultation before use. To ensure medication safety, disclose all other medications to your doctor, as interactions may occur. Alcohol consumption should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be conducted by your physician throughout therapy.

Uses of Sitapride-M 50mg/500mg Tablet PR

Managing type 2 diabetes

Major Benefits of Sitapride-M 50mg/500mg Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Sitapride-M 50mg/500mg Tablet PR with a meal.

Common Side effects of Sitapride-M 50mg/500mg Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitapride-M 50mg/500mg Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Administer Sitapride-M 50mg/500mg Tablet PR with meals.

How Sitapride-M 50mg/500mg Tablet PR works:

Sitagliptin/metformin 50mg/500mg tablets (Sitapride-M PR) combine two medications to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, enhances insulin effectiveness, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action optimizes blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Sitapride-M 50mg/500mg Tablet PR ingestion poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Sitapride-M 50mg/500mg tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitapride-M 50mg/500mg tablets during lactation is likely inadvisable. Available data from human studies indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

The use of Sitapride-M 50mg/500mg Tablet PR requires careful consideration in individuals with impaired renal function. Dosage modification of Sitapride-M 50mg/500mg Tablet PR may be necessary. Physician consultation is recommended. For patients exhibiting severe kidney disease, Sitapride-M 50mg/500mg Tablet PR is contraindicated. Routine monitoring of kidney function is advised during treatment.

LiverLiverUNSAFE

The use of Sitapride-M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitapride-M 50mg/500mg Tablet PR :

For omitted Sitapride-M 50mg/500mg Tablet PR, administer the dose at your earliest convenience. If your next scheduled dose is imminent, however, forgo the missed dose and resume your usual dosing regimen. Avoid exceeding the prescribed dosage.

Facts to Know About Sitapride-M 50mg/500mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitapride-M 50mg/500mg Tablet PR

Sitapride-M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Sitapride-M 50mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. Preventive measures suggested by some researchers include annual supplemental vitamin B12 intake.
Sitapride-M 50mg/500mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Sitapride-M 50mg/500mg Tablet PR components or excipients should not use it. This medication is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitapride-M 50mg/500mg Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Sitagliptin + Metformin (like Sitapride-M 50mg/500mg Tablet PR) can rarely cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also called Metformin-associated lactic acidosis or MALA). This risk is increased in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking the medication and seek immediate medical attention.
Sitapride-M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitapride-M 50mg/500mg Tablet PR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitapride-M 50mg/500mg Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitapride-M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitapride-M 50mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sitapride-M 50mg/500mg Tablet PR can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitapride-M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitapride-M 50mg/500mg Tablet PR commonly causes hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitapride-M 50mg/500mg Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitapride-M 50mg/500mg Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitapride-M 50mg/500mg Tablet PR) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, Metformin-associated lactic acidosis). This rare side effect necessitates avoiding its use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitapride-M 50mg/500mg Tablet PR use can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Sitapride-M 50mg/500mg Ta...
128
MRP 149
14% off